STOCK TITAN

Gyrodyne (GYRO) Stock News

GYRO Nasdaq

Welcome to our dedicated page for Gyrodyne news (Ticker: GYRO), a resource for investors and traders seeking the latest updates and insights on Gyrodyne stock.

Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties in the New York metropolitan area. Its assets include the Flowerfield property in St. James, New York, with industrial, office and undeveloped land, and a medical office park in Cortlandt Manor, New York.

Gyrodyne news commonly centers on property entitlements, parcel sale agreements, litigation affecting land-use approvals, and the company’s strategic liquidation process. Updates also cover capital actions such as rights offerings, shareholder engagement agreements, board composition, director compensation limits, and annual meeting matters tied to its common shares of limited liability company interests on Nasdaq.

News
Rhea-AI Summary

Gyrodyne, LLC (Nasdaq: GYRO) issued a letter to shareholders from CEO Gary Fitlin on January 30, 2023, highlighting the company's continued focus on real estate with medical tenants, which has resulted in $147 million returned to shareholders. The company aims to maximize property values and distribute net asset values before dissolving by the end of 2024. Gyrodyne is addressing corporate governance concerns following the 2022 Annual Meeting and has made significant progress with its properties, including the Flowerfield and Cortlandt Manor sites. The company maintains a strong balance sheet, with debt at $9.8 million and a loan-to-value ratio of 23%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.7%
Tags
none
-
Rhea-AI Summary

Gyrodyne, LLC (NASDAQ: GYRO) announced that the Town of Smithtown Planning Board granted preliminary subdivision approval for its Flowerfield property on March 30, 2022. The approval is contingent on finalizing a stormwater pollution prevention plan and other requirements. This milestone follows extensive public comment and analysis under the State Environmental Quality Review Act (SEQRA). Gyrodyne is set to advance to final subdivision approval, needing further reviews from local and state authorities. The company will actively market the subdivided lots while seeking attractive offers for the property.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.92%
Tags
none

FAQ

What is the current stock price of Gyrodyne (GYRO)?

The current stock price of Gyrodyne (GYRO) is $6.22 as of June 11, 2026.

What is the market cap of Gyrodyne (GYRO)?

The market cap of Gyrodyne (GYRO) is approximately 13.7M.